Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Wasif Saif

Showing results (311-320 of 473) with videos related to

Pageof 48
Sort By:
JOP : Journal of the Pancreas|July 9, 2011
Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Alexios S Strimpakos, Kostas N Syrigos, Muhammad Wasif Saif
Expert Opinion on Drug Safety|October 14, 2014
Hypersensitivity reactions associated with oxaliplatin and their clinical managementMaria I Toki, Muhammad Wasif Saif, Kostantinos N Syrigos
JOP : Journal of the Pancreas|July 31, 2014
Targeted agents in treatment of neuroendocrine tumors of pancreasIlias N Karampelas, Kostas N Syrigos, Muhammad Wasif Saif
Oncotargets and Therapy|March 2, 2016
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumorsElias A Kotteas, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 12, 2005
Gastrointestinal bleeding associated with concurrent capecitabine and radiotherapy in patients with pancreatic cancerMuhammad Wasif Saif, John S Moody, Suzanne M Russo
The Yale Journal of Biology and Medicine|July 1, 2010
Role and cost effectiveness of PET/CT in management of patients with cancerMuhammad Wasif Saif, Ifigenia Tzannou, Nektaria Makrilia, et al.
JOP : Journal of the Pancreas|September 7, 2010
Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancerKrishna S Gunturu, Maysa Abu-Khalaf, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 6, 2010
Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Anastasios T Dimou, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|May 21, 2009
Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancerJia Li, Jennifer Peccerillo, Kristin Kaley, et al.
JOP : Journal of the Pancreas|January 9, 2009
Depression and pancreatic cancer: a poorly understood linkNektaria Makrilia, Bonnie Indeck, Kostas Syrigos, et al.
Pageof 48

Showing results (311-320 of 473) with videos related to

Sort By:
Pageof 48
JOP : Journal of the Pancreas|July 9, 2011
Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Alexios S Strimpakos, Kostas N Syrigos, Muhammad Wasif Saif
Expert Opinion on Drug Safety|October 14, 2014
Hypersensitivity reactions associated with oxaliplatin and their clinical managementMaria I Toki, Muhammad Wasif Saif, Kostantinos N Syrigos
JOP : Journal of the Pancreas|July 31, 2014
Targeted agents in treatment of neuroendocrine tumors of pancreasIlias N Karampelas, Kostas N Syrigos, Muhammad Wasif Saif
Oncotargets and Therapy|March 2, 2016
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumorsElias A Kotteas, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 12, 2005
Gastrointestinal bleeding associated with concurrent capecitabine and radiotherapy in patients with pancreatic cancerMuhammad Wasif Saif, John S Moody, Suzanne M Russo
The Yale Journal of Biology and Medicine|July 1, 2010
Role and cost effectiveness of PET/CT in management of patients with cancerMuhammad Wasif Saif, Ifigenia Tzannou, Nektaria Makrilia, et al.
JOP : Journal of the Pancreas|September 7, 2010
Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancerKrishna S Gunturu, Maysa Abu-Khalaf, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 6, 2010
Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Anastasios T Dimou, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|May 21, 2009
Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancerJia Li, Jennifer Peccerillo, Kristin Kaley, et al.
JOP : Journal of the Pancreas|January 9, 2009
Depression and pancreatic cancer: a poorly understood linkNektaria Makrilia, Bonnie Indeck, Kostas Syrigos, et al.
Pageof 48